Cargando…
Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2
Pre-clinical and on-going trials have indicated the advantage of using metformin as an anticancer drug alone or in combination with other chemotherapeutics for the treatment of patients with breast cancer. However, the mechanisms by which metformin attenuates tumorigenesis remain to be further eluci...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243079/ https://www.ncbi.nlm.nih.gov/pubmed/34257723 http://dx.doi.org/10.3892/ol.2021.12876 |